The most dependable general medicine thesis topics in India are biomarker correlation studies such as serum magnesium, uric acid, lipid ratios or HbA1c against disease severity; prognostic score validation studies in sepsis, pneumonia, cirrhosis, stroke or poisoning; clinical and aetiological profile studies in dengue, scrub typhus, fever of unknown origin, pancytopenia or acute kidney injury; and prevalence studies of complications in diabetes, hypertension or chronic kidney disease. All of them run on patients already admitted to your wards and use investigations your laboratory already performs.

Yes. Every section is open — the full topic lists are free to read, copy and discuss with your guide, with no subscription and no login required to see the topics.

Define a single hard outcome — in-hospital mortality, ICU admission, need for ventilation or dialysis, length of stay — and record the score at a fixed time point, usually within twenty-four hours of admission. Report discrimination using the area under the receiver operating characteristic curve with its confidence interval, identify the optimal cut-off with its sensitivity, specificity and predictive values, and where your sample permits, assess calibration with the Hosmer–Lemeshow test. If you are comparing two scores, compare their curves formally rather than eyeballing the areas. Prognostic score studies are among the strongest MD medicine theses because the scores are free, the data are routine and the results are directly publishable.

Three recur. First, availability — confirm the marker is run routinely in your own laboratory rather than sent out, and that reagent supply is stable across your data-collection period. Second, timing — state exactly when the sample is drawn relative to admission or treatment, because many markers change within hours. Third, confounding — renal function, liver function, age and concurrent medication affect most biochemical markers, so either exclude these or record and adjust for them. Correlation alone rarely satisfies a reviewer; pairing it with a severity score or an outcome gives the study clinical meaning.

It can be, but it carries a risk other topics do not: you cannot recruit patients who do not arrive. A weak season can leave you well short of your sample size with no way to catch up before submission. Before committing, check admission numbers across at least two previous years, calculate your sample size conservatively, and build in a longer data-collection window. Consider a design that tolerates a smaller sample, such as a profile study rather than a comparative one, or broaden the inclusion to acute febrile illness with the specific infection as a subgroup.

There is no universal number. Prevalence studies size on the expected proportion from a cited study, an alpha of 0.05 and an absolute precision you set. Correlation studies size on the expected correlation coefficient. Prognostic score studies size on the expected area under the curve or on the number of outcome events — a model needs enough deaths or ICU admissions, not just enough patients. Comparative studies size on the difference between groups. Most single-centre MD medicine studies land between 80 and 150 participants, but the calculation and its source must appear in the protocol.

Through a legally acceptable representative, with a plan to seek the patient's own consent once they regain capacity. This applies to much of emergency medicine, poisoning, stroke, sepsis and intensive care research. The protocol should state who qualifies as the representative, how consent will be documented, what happens if the patient later declines, and whether any data collected before recovery will be retained. Where the study involves only routine care and observation, some ethics committees will consider deferred consent or a waiver — but that decision is theirs, not yours, and it must be requested explicitly.

Yes. The clinical questions are the same; only the document format differs. Saudi Board of Internal Medicine residents need an SCFHS-style research proposal for IRB submission, which is shorter than an Indian thesis synopsis and places more emphasis on feasibility, budget, timeline and data management. Match the topic to the Gulf case mix — diabetes, obesity, metabolic liver disease, chronic kidney disease and haemoglobinopathies offer far larger local numbers than tropical infections. Use the international link above to request that format.

Yes. Arab Board of Internal Medicine trainees, residents licensed under DHA, DOH and MOHAP in the UAE, QCHP and HMC residents in Qatar, OMSB residents in Oman, KIMS residents in Kuwait and NHRA-licensed trainees in Bahrain can all use these titles. What changes between countries is the ethics pathway, the proposal template and the local disease mix — not the research question itself. Ethics committee approval before data collection is required everywhere, and data gathered before the approval date is generally not accepted.